July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead

COVID-19
David DeRemer, PharmD, BCOP, FCCP, FHOPA
Clinical Associate Professor
University of Florida College Pharmacy
Michael Joyner, MD
Professor, Mayo Clinic
Maurie Markman, MD
President
Medicine & Science
Cancer Treatment Centers of America
Kevin O’Hayer, MD, PhD
Senior Director, Immuno-Oncology
Incyte Corporation
Bhavesh Shah, RPh, BCOP
Director of Specialty and Hematology/Oncology Pharmacy, Boston Medical Center
Mark Sloan, MD
Associate Professor of Medicine
Boston University School of Medicine
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?

Related Articles

mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
By Chase Doyle
COVID-19
February 2022, Vol 13, No 1 Online Only
Read Article
Current and Future Effects of the COVID-19 Pandemic on Cancer Care
By Phoebe Starr
COVID-19
June 2021, Vol 12, No 3
Read Article
Later Diagnoses, Worse Outcomes in Patients with Lung Cancer During COVID-19 May Last
By Walter Alexander
COVID-19, Lung Cancer
April 2021, Vol 12, No 2
Read Article
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care
By Walter Alexander
COVID-19
April 2021, Vol 12, No 2
Read Article
AVBCC Celebrates World Cancer Day
By Burt Zweigenhaft, PhD, D.Litt
Videos
Read Article
Managing Cholangiocarcinoma in the Setting of COVID-19: Unique Challenges and Opportunities
By Ghassan K. Abou-Alfa, MD, MBA; Bruce Lin, MD; Farshid Dayyani, MD, PhD; Richard Kim, MD; Rachna T. Shroff, MD, MS; Melinda Bachini; Milind M. Javle, MD
Cholangiocarcinoma, COVID-19
December 2020, Special Issue: Managing CCA in the Setting of COVID-19
Read Article
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
By Phoebe Starr
AACR COVID-19 Highlights, COVID-19
October 2020, Vol 11, No 5
Read Article
Cancer Drugs Show Promise as Potential Treatment for COVID-19
COVID-19
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
Managed Care, Oncology, and Telehealth in the Era of COVID-19
COVID-19
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?